Medical device company Sequana names new chairman

Switzerland-based Sequana Medical has appointed a new chairman to their board of directors as the company expands its international commercialization of its fluid pump.

Sequana named Rolf Classon, a former top executive of Germany-based Bayer, chairman of the board, the company announced in a statement today. 

"We are delighted to welcome Rolf in the key position of chairman," said Noel Johnson, CEO of Sequana Medical. "His extensive experience as a senior officer and board member of a number of international medical device, pharmaceutical and biotechnology companies, gives him an excellent vantage point from which to help steer Sequana Medical in the next phase of its growth."

Sequana is a commercial medical device company known for its alfapump system, an implantable battery-powered pump that manages abdomen fluid build-up.

Classon also serves on the boards of Catalent Pharma Solutions, Fresenius Medical Care, Hill-Rom Holdings and Tecan Goup. He was the interim president and CEO of Batesville, Ind.-based Hillenbrand Industries from 2005-2006.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”